CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 33 filers reported holding CYTEIR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,920,916 | -79.8% | 676,379 | -81.5% | 0.14% | -80.7% |
| Q2 2023 | $9,522,854 | -91.6% | 3,662,636 | -7.0% | 0.74% | -90.1% |
| Q1 2023 | $112,892,832 | +1636.4% | 3,940,413 | 0.0% | 7.45% | +1734.7% |
| Q4 2022 | $6,501,681 | -14.1% | 3,940,413 | 0.0% | 0.41% | +12.5% |
| Q3 2022 | $7,566,000 | -47.7% | 3,940,413 | -18.6% | 0.36% | -49.4% |
| Q2 2022 | $14,473,000 | -20.7% | 4,840,413 | 0.0% | 0.71% | -26.0% |
| Q1 2022 | $18,248,000 | -66.8% | 4,840,413 | 0.0% | 0.96% | -63.0% |
| Q4 2021 | $55,035,000 | -35.2% | 4,840,413 | 0.0% | 2.61% | -40.7% |
| Q3 2021 | $84,949,000 | -18.0% | 4,840,413 | 0.0% | 4.39% | -4.4% |
| Q2 2021 | $103,585,000 | – | 4,840,413 | – | 4.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 2,474,572 | $9,329,000 | 7.10% |
| Novo Holdings A/S | 4,840,413 | $18,248,000 | 0.96% |
| RA Capital Management | 3,350,506 | $12,631,000 | 0.28% |
| Avidity Partners Management LP | 1,850,000 | $6,975,000 | 0.14% |
| ACT CAPITAL MANAGEMENT, LLC | 15,000 | $57,000 | 0.06% |
| Baker Brothers Advisors | 812,640 | $3,064,000 | 0.02% |
| CAAS CAPITAL MANAGEMENT LP | 105,091 | $396,000 | 0.02% |
| Evercore Wealth Management, LLC | 146,676 | $553,000 | 0.01% |
| Jump Financial, LLC | 21,300 | $80,000 | 0.00% |
| JANUS HENDERSON GROUP PLC | 1,719,610 | $6,486,000 | 0.00% |